Clinical Plenary #1

Presentations

11:30 AM - 11:45 AM
Apr 29 2026
Washington, D.C.

Long-term data of elafibranor in primary sclerosing cholangitis: Interim safety and efficacy data from the ongoing open-label extension of the ELMWOOD phase II trial

Christopher L Bowlus, MD, FAASLD , Abstract Presenter
Cholestatic and Autoimmune
Cirrhosis and Portal Hypertension
Liver Cancer